Mayo Test Catalog, (Sorted By Test Name) - Mayo Medical ...

CDAU1
80917
CDAU7
81410
Test Performed By: Focus Diagnostics, Inc.
5785 Corporate Avenue
Cypress, CA 90630-4750
Drug Abuse Survey with Confirmation, Evaluation 1, Urine
Clinical Information: This test was designed to screen for and confirm by gas
chromatography-mass spectrometry (GC-MS) or gas chromatography-flame ionization detection
(GC-FID) the following drugs: -Amphetamines -Barbiturates -Cocaine -Ethanol -Methadone -Opiates
-Phencyclidine -Propoxyphene This assay represents the coupling of IDOAU/8248 Drug Abuse Survey,
Urine with an automatic confirmation of all positive results by the definitive assay available and
described elsewhere (eg, AMPHU/8257 Amphetamines, Urine). All positive screening results are
confirmed by GC-MS or GC-FID, and quantitated, before a positive result is reported.
Useful For: Detecting drug abuse involving amphetamines, barbiturates, cocaine, ethanol,
methadone, opiates, phencyclidine, and propoxyphene This test is intended to be used in a setting where
the test results can be used definitively to make a diagnosis.
Interpretation: A positive result indicates that the patient has used the drugs detected in the recent
past. See individual tests (eg, AMPHU/8257 Amphetamines, Urine) for more information. For
information about drug testing, including estimated detection times, see Drugs of Abuse Testing at
http://www.mayomedicallaboratories.com/articles/drug-book/index.html Creatinine and specific gravity
are measured as indicators of specimen dilution.
Reference Values:
Negative
Screening cutoff concentrations
Amphetamines: 500 ng/mL
Barbiturates: 200 ng/mL
Cocaine (benzoylecgonine-cocaine metabolite): 150 ng/mL
Ethanol: 30 mg/dL
Methadone: 300 ng/mL
Opiates: 300 ng/mL
Phencyclidine: 25 ng/mL
Propoxyphene: 300 ng/mL
This report is intended for use in clinical monitoring or management of patients. It is not intended for
use in employment-related testing.
Clinical References: 1. Physicians Desk Reference (PDR). 60th edition. Montvale, NJ, Medical
Economics Company, 2006 2. Goodman and Gilman's The Pharmacological Basis of Therapeutics. 11th
edition. Edited by LL Bruntman. New York, McGraw-Hill Book Company, 2006 3. Langman LJ,
Bechtel L, Holstege CP: Chapter 35. Tietz Textbook of Clinical Chemistry and Molecular Diagnostics.
Edited by CA Burtis, ER Ashwood, DE Bruns. WB Saunders Company, 2011, pp 1109-1188
Drug Abuse Survey with Confirmation, Evaluation 12, Urine
Clinical Information: This assay was designed to test for and confirm by gas
chromatography-mass spectrometry (GC-MS) the most common classes of drugs of abuse. This test
uses the simple screening technique described under IDOAU/8248 Drug Abuse Survey, Urine, which
involves immunologic testing for drugs by class. All positive screening results are confirmed by
GC-MS (positive alcohol by GC), and quantitated, before a positive result is reported. This test
represents the coupling of IDOAU/8248 Drug Abuse Survey, Urine with an automatic confirmation of
all positive results by the definitive assay available and described elsewhere (eg, AMPHU/8257
Amphetamines, Urine).
Useful For: Detecting drug abuse involving alcohol, amphetamines, barbiturates, benzodiazepines,
cocaine, methadone, opiates, phencyclidine, propoxyphene, and tetrahydrocannabinol This test is
Current as of January 3, 2013 2:22 pm CST 800-533-1710 or 507-266-5700 or MayoMedicalLaboratories.com Page 633